Product Information
OLOPATADINE HCL 0.2% EYE DROP is a generic product labeled by Chain Drug Marketing Association, priced at $2.9636 per ML under NDC 83324012025. Its NADAC has been published 88 times since Jan 29, 2025.
FDA first approved this application on May 20, 2020.
The High Outlier badge above means this manufacturer's average price in the Olopatadine Hydrochloride Ophthalmic market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2 mg/mL
Manufacturer
Chain Drug Marketing AssociationNDC
83324012025
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
OLOPATADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209752FDA Approved
5/20/2020
On Market Since
1/1/2021
Pharmacological Classes
Price Statistics
The NADAC for OLOPATADINE HCL 0.2% EYE DROP has been published 88 times since Jan 29, 2025, and over the history we have for it it has declined 19.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.9636 per ML |
|---|---|
| All-time high | $3.7687 (Mar 12, 2025) |
| All-time low | $2.9636 (Sep 23, 2026) |
| 52-week high | $3.6822 |
| 52-week low | $2.9636 |
| Median price | $3.4709 |
| Average price | $3.4001 |
| Largest weekly change | -5.7% (Apr 23, 2025) |
| Weeks tracked | 88 |
| Tracking since | Jan 29, 2025 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Olopatadine Hydrochloride Ophthalmic market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OLOPATADINE HCL 0.2% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for OLOPATADINE HCL 0.2% EYE DROP, manufactured by Chain Drug Marketing Association, is $2.9636 per ML (NDC 83324012025), effective Sep 30, 2026.
How has the price of OLOPATADINE HCL 0.2% EYE DROP changed over time?
Over the history we have for it, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has declined 19.6%. It has been tracked across 88 weekly CMS publications since Jan 29, 2025.
What are the highest and lowest recorded NADAC prices for OLOPATADINE HCL 0.2% EYE DROP?
Since Jan 29, 2025, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has ranged from a low of $2.9636 (Sep 23, 2026) to a high of $3.7687 (Mar 12, 2025), with a median of $3.4709 per ML.
Are there cheaper alternatives to OLOPATADINE HCL 0.2% EYE DROP?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLOPATADINE HCL 0.2% EYE DROP in a comparable dosage form, but none are currently priced below it.
Who manufactures OLOPATADINE HCL 0.2% EYE DROP?
OLOPATADINE HCL 0.2% EYE DROP (NDC 83324012025) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.